Stock Market News

Genmab sinks as J&J opts not to develop Darzalex successor; stock upgraded

Mar 11, 2025 - 11:47
 0
Genmab sinks as J&J opts not to develop Darzalex successor; stock upgraded
Read More

Tags:

Previous Article

Redcare Pharmacy stock jumps 13% after strong FY25 guidance and Rx growth

Next Article

Areas of "over-optimism" in European stock rally seen fading, Morgan Stanley says

Related Posts

French antitrust agency probing Microsoft over Bing access, Bloomberg reports

French antitrust agency probing Microsoft over Bing acc...

Feb 10, 2025  0

Kenvue settles proxy fight with activist Starboard, appoints three directors

Kenvue settles proxy fight with activist Starboard, app...

Mar 5, 2025  0

Tesla stock selloff: Why this is a ‘Moment of Truth’ for Musk and EV maker

Tesla stock selloff: Why this is a ‘Moment of Truth’ fo...

Mar 11, 2025  0